Last edition
News about "colorectal cancer"
CuraTeQ Biologics Secures CDSCO Approval for Bevqolva
CuraTeQ Biologics receives CDSCO marketing authorisation for Bevqolva, strengthening its oncology biosimilars portfolio and expanding access to advanced cancer therapies.
Colorectal Cancer | 16/05/2026 | By News Bureau
CStone's CS2009 Secures U.S. FDA IND Clearance for Phase II Trial in Advanced Solid Tumours
CStone Pharmaceuticals has received U.S. FDA IND clearance to begin a Phase II trial of its trispecific antibody CS2009 for advanced solid tumours, advancing its global immunotherapy development programme.
Colorectal Cancer | 16/02/2026 | By News Bureau | 139
SK Biopharmaceuticals Expands Radiopharma Portfolio with New WARF In-Licensing
SK Biopharmaceuticals has in-licensed a second radiopharmaceutical therapy candidate from the Wisconsin Alumni Research Foundation (WARF), further strengthening its pipeline and advancing its strategy to build an integrated, globally competitive radiotherapeutics portfolio.
Colorectal Cancer | 29/11/2025 | By Dineshwori | 243
Bayer and Kumquat Biosciences have begun a Phase-I trial of their KRAS G12D inhibitor targeting KRAS-mutated tumors, further bolstering Bayer’s precision oncology pipeline across pancreatic, colorectal, and lung cancers.
Colorectal Cancer | 11/10/2025 | By Dineshwori | 720
BioDlink Launches Bevacizumab Biosimilar in Colombia and Pakistan
BioDlink’s bevacizumab injection secures marketing authorization in Colombia and Pakistan following its recent approval in Nigeria.<br />
Colorectal Cancer | 14/08/2025 | By Dineshwori | 256
Workflow Services and Exact Sciences to Provide Easy Access of Colorectal Cancer Screening
Workflow Services has signed a new agreement with Exact Sciences, a biotechnology company that develops tests designed to prevent, detect, and guide the successful treatment of cancer.
Colorectal Cancer | 30/03/2024 | By Manvi | 538
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy